Rigel Pharmaceuticals Inc
NASDAQ:RIGL

Watchlist Manager
Rigel Pharmaceuticals Inc Logo
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Watchlist
Price: 41.59 USD -0.43% Market Closed
Market Cap: 754.9m USD

Wall Street
Price Targets

RIGL Price Targets Summary
Rigel Pharmaceuticals Inc

Wall Street analysts forecast RIGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RIGL is 46.24 USD with a low forecast of 24.24 USD and a high forecast of 72.45 USD.

Lowest
Price Target
24.24 USD
42% Downside
Average
Price Target
46.24 USD
11% Upside
Highest
Price Target
72.45 USD
74% Upside
Rigel Pharmaceuticals Inc Competitors:
Price Targets
RYTM
Rhythm Pharmaceuticals Inc
23% Upside
688177
Bio-Thera Solutions Ltd
59% Upside
IONS
Ionis Pharmaceuticals Inc
10% Upside
300685
Amoy Diagnostics Co Ltd
43% Upside
6855
Ascentage Pharma Group International
84% Upside
ARQT
Arcutis Biotherapeutics Inc
15% Upside
CAPR
Capricor Therapeutics Inc
86% Upside
EXEL
Exelixis Inc
4% Upside

Revenue
Forecast

Revenue Estimate
Rigel Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Rigel Pharmaceuticals Inc's revenue is 32%. The projected CAGR for the next 4 years is 22%.

32%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Rigel Pharmaceuticals Inc

The compound annual growth rate of Rigel Pharmaceuticals Inc's operating income for the next 4 years is 58%.

N/A
Past Growth
58%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Rigel Pharmaceuticals Inc

The compound annual growth rate of Rigel Pharmaceuticals Inc's net income for the next 4 years is 51%.

N/A
Past Growth
51%
Estimated Growth
Estimates Accuracy
-28%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RIGL's stock price target?
Price Target
46.24 USD

According to Wall Street analysts, the average 1-year price target for RIGL is 46.24 USD with a low forecast of 24.24 USD and a high forecast of 72.45 USD.

What is Rigel Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
22%

For the last 13 years the compound annual growth rate for Rigel Pharmaceuticals Inc's revenue is 32%. The projected CAGR for the next 4 years is 22%.

What is Rigel Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
58%

The compound annual growth rate of Rigel Pharmaceuticals Inc's operating income for the next 4 years is 58%.

What is Rigel Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
51%

The compound annual growth rate of Rigel Pharmaceuticals Inc's net income for the next 4 years is 51%.

Back to Top